Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Frankel

Showing results (331-340 of 348) with videos related to

Pageof 35
Sort By:
JAMA Oncology|August 26, 2021
Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma: A Phase 2 Randomized Clinical TrialSumanta K Pal, Paul H Frankel, Amir Mortazavi, et al.
British Journal of Cancer|October 29, 2014
Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumorsM Koczywas, P H Frankel, T W Synold, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2011
Sequential bortezomib, dexamethasone, and thalidomide maintenance therapy after single autologous peripheral stem cell transplantation in patients with multiple myelomaFiroozeh Sahebi, Paul H Frankel, Len Farol, et al.
Pleura and Peritoneum|December 23, 2022
Multicenter dose-escalation Phase I trial of mitomycin C pressurized intraperitoneal aerosolized chemotherapy in combination with systemic chemotherapy for appendiceal and colorectal peritoneal metastases: rationale and designMustafa Raoof, Kevin M Sullivan, Paul H Frankel, et al.
The Oncologist|November 3, 2020
A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast CancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Frontiers in Oncology|August 16, 2024
Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): sub-cohort report of phase 1 clinical trialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Iscience|July 18, 2022
Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variantsFlavia Chiuppesi, John A Zaia, Katelyn Faircloth, et al.
Annals of Surgical Oncology|October 1, 2025
Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients with Ovarian Cancer with Peritoneal Metastases: A Multicenter US Phase I TrialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Annals of Surgical Oncology|October 29, 2025
ASO Visual Abstract: Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Ovarian Cancer Patients with Peritoneal Metastases-A Multicenter U.S. Phase I TrialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
The Oncologist|October 24, 2020
Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast CancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Pageof 35

Showing results (331-340 of 348) with videos related to

Sort By:
Pageof 35
JAMA Oncology|August 26, 2021
Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma: A Phase 2 Randomized Clinical TrialSumanta K Pal, Paul H Frankel, Amir Mortazavi, et al.
British Journal of Cancer|October 29, 2014
Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumorsM Koczywas, P H Frankel, T W Synold, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2011
Sequential bortezomib, dexamethasone, and thalidomide maintenance therapy after single autologous peripheral stem cell transplantation in patients with multiple myelomaFiroozeh Sahebi, Paul H Frankel, Len Farol, et al.
Pleura and Peritoneum|December 23, 2022
Multicenter dose-escalation Phase I trial of mitomycin C pressurized intraperitoneal aerosolized chemotherapy in combination with systemic chemotherapy for appendiceal and colorectal peritoneal metastases: rationale and designMustafa Raoof, Kevin M Sullivan, Paul H Frankel, et al.
The Oncologist|November 3, 2020
A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast CancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Frontiers in Oncology|August 16, 2024
Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): sub-cohort report of phase 1 clinical trialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Iscience|July 18, 2022
Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variantsFlavia Chiuppesi, John A Zaia, Katelyn Faircloth, et al.
Annals of Surgical Oncology|October 1, 2025
Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients with Ovarian Cancer with Peritoneal Metastases: A Multicenter US Phase I TrialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Annals of Surgical Oncology|October 29, 2025
ASO Visual Abstract: Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Ovarian Cancer Patients with Peritoneal Metastases-A Multicenter U.S. Phase I TrialBrad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
The Oncologist|October 24, 2020
Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast CancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Pageof 35